Dr. Trinh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4025 N Sheridan Rd
Chicago, IL 60613Phone+1 773-388-1600Fax+1 773-388-8936
Summary
- Dr. Roger Trinh is an internist in Chicago, IL. He received his medical degree from Northwestern University Feinberg School of Medicine and has been in practice 18 years. He specializes in hiv/aids medicine.
Education & Training
- McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1999 - 2002
- Northwestern University The Feinberg School of MedicineClass of 1999
Certifications & Licensure
- IL State Medical License 2002 - 2026
- American Board of Internal Medicine Internal Medicine
Clinical Trials
- A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis Start of enrollment: 2014 Nov 24
- A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis Start of enrollment: 2014 Sep 01
Publications & Presentations
PubMed
- Efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir with low-dose ribavirin in patients with chronic hepatitis C virus genotype 1a infection without...Fred Poordad, Shahriar Sedghi, Paul J. Pockros, Natarajan Ravendhran, Robert Reindollar
Journal of Viral Hepatitis. 2019-08-01 - 28 citationsGlecaprevir/Pibrentasvir in patients with chronic HCV genotype 3 infection: An integrated phase 2/3 analysisSteven L. Flamm, David Mutimer, Armen Asatryan, Stanley Wang, Jürgen K. Rockstroh
Journal of Viral Hepatitis. 2019-03-01 - 23 citationsSafety and efficacy of glecaprevir/pibrentasvir for the treatment of chronic hepatitis C in patients aged 65 years or olderGraham R. Foster, Tarik Asselah, Sarah Kopecky-Bromberg, Yang Lei, Armen Asatryan
Plos One. 2019-01-02
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: